Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Sell
7,976
-12,233
-61% -$270K 0.01% 1482
2026
Q1
$295K Sell
20,209
-65,966
-77% -$968K 0.02% 1263
2025
Q4
$1.09M Buy
86,175
+64,217
+292% +$947K 0.09% 316
2025
Q3
$338K Sell
21,958
-58,971
-73% -$951K 0.03% 1129
2025
Q2
$1.27M Buy
+80,929
New +$1.23M 0.09% 324
2024
Q2
Sell
-56,002
Closed -$1.23M 1971
2024
Q1
$1.23M Buy
56,002
+45,510
+434% +$975K 0.1% 318
2023
Q4
$244K Sell
10,492
-44,585
-81% -$897K 0.02% 1221
2023
Q3
$1.09M Buy
55,077
+42,123
+325% +$830K 0.09% 355
2023
Q2
$294K Buy
+12,954
New +$261K 0.03% 1061

Other funds holding RXO

GSA Capital Partners's RXO Position: Q2 2026 in Review

GSA Capital Partners reduced its RXO (RXO) stake by 61% in Q2 2026, selling an estimated $270K and leaving 7,976 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #1482.

GSA Capital Partners first reported a position in RXO in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.27M in Q2 2025. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • GSA Capital Partners held 7,976 shares of RXO worth $220K as of Q2 2026.
  • GSA Capital Partners sold 12,233 RXO shares in Q2 2026, an estimated $270K.
  • RXO made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1482 holding.
  • GSA Capital Partners first reported a position in RXO in Q2 2023 and has held it in 9 quarters since.
  • GSA Capital Partners's RXO position peaked at $1.27M in Q2 2025.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.